PSMB9 Protein

PSMB9 Protein

Overview

Psmb9 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<!-- Protein Page --> [@ferrington2008]
<div class="infobox infobox-protein"> [@groll2000]
<h3>PSMB9 Protein (LMP2)</h3> [@aiken2011]
<div class="infobox-row"><strong>Protein Name:</strong> Proteasome Subunit Beta Type-9</div> [@rock2002]
<div class="infobox-row"><strong>Gene:</strong> PSMB9</div> [@hegde2004]
<div class="infobox-row"><strong>UniProt ID:</strong> P28065</div> [@mishto2015]
<div class="infobox-row"><strong>PDB Structure IDs:</strong> 5MGK, 6AP4, 6ANA</div> [@orre2013]
<div class="infobox-row"><strong>Molecular Weight:</strong> 23.2 kDa</div> [@farotti2019]
<div class="infobox-row"><strong>Subcellular Localization:</strong> Cytoplasm, nucleus</div> [@ebrahimifakhari2016]
<div class="infobox-row"><strong>Protein Family:</strong> Immunoproteasome beta-type subunit, PA20 family</div> [@ge2012]
<div class="infobox-row"><strong>Expression:</strong> Constitutive in immune cells; inducible in neurons under IFN-γ</div> [@cheroni2009]
</div> [@feric2018]

Introduction

PSMB9 Protein

Overview

Psmb9 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<!-- Protein Page --> [@ferrington2008]
<div class="infobox infobox-protein"> [@groll2000]
<h3>PSMB9 Protein (LMP2)</h3> [@aiken2011]
<div class="infobox-row"><strong>Protein Name:</strong> Proteasome Subunit Beta Type-9</div> [@rock2002]
<div class="infobox-row"><strong>Gene:</strong> PSMB9</div> [@hegde2004]
<div class="infobox-row"><strong>UniProt ID:</strong> P28065</div> [@mishto2015]
<div class="infobox-row"><strong>PDB Structure IDs:</strong> 5MGK, 6AP4, 6ANA</div> [@orre2013]
<div class="infobox-row"><strong>Molecular Weight:</strong> 23.2 kDa</div> [@farotti2019]
<div class="infobox-row"><strong>Subcellular Localization:</strong> Cytoplasm, nucleus</div> [@ebrahimifakhari2016]
<div class="infobox-row"><strong>Protein Family:</strong> Immunoproteasome beta-type subunit, PA20 family</div> [@ge2012]
<div class="infobox-row"><strong>Expression:</strong> Constitutive in immune cells; inducible in neurons under IFN-γ</div> [@cheroni2009]
</div> [@feric2018]

Introduction

Proteasome Subunit Beta Type-9 (PSMB9), also known as LMP2 (Low Molecular Weight Protein 2), is a catalytic subunit of the immunoproteasome. Unlike the constitutive proteasome, the immunoproteasome generates peptides optimized for MHC class I presentation, playing a crucial role in immune surveillance and inflammatory responses [1]. [@maruszczak2015]

In the brain, PSMB9 is expressed at low levels under normal conditions but is dramatically upregulated in response to neuroinflammation, where it participates in the degradation of oxidized, misfolded, and aggregate-prone proteins [2]. [@mishto2012]

Structure

PSMB9 has a characteristic N-terminal threonine protease active site characteristic of the proteasome β-subunit family: [@seong2010]

Catalytic Core

• N-terminal Threonine (Thr1): The active site nucleophile for proteolysis
• Proline-rich hinge region: Allows conformational flexibility
• Conserved β-sheet core: Provides structural stability

Assembly

• Four stacked heptameric rings (α7β7β7α7)
• Two inner β-rings contain the catalytic subunits (β1i/PSMB9, β2i/PSMB10, β5i/PSMB8)
• The immunoproteasome replaces the constitutive β1 (PSMB6), β2 (PSMB7), and β5 (PSMB5) subunits [3]

Post-Translational Modifications

• Phosphorylation: Serine/threonine phosphorylation regulates proteasome assembly and activity
• Acetylation: Lysine acetylation affects protein-protein interactions
• Oxidation: Methionine oxidation can temporarily inactivate the proteasome [4]

Normal Function

Immunoproteasome Assembly

• Cleavage Specificity: Preferentially cleaves after hydrophobic and basic residues (trypsin-like and chymotrypsin-like)
• Peptide Generation: Produces peptides optimized for MHC class I binding
• Immune Function: Essential for CD8+ T cell activation and immune surveillance [1]

Cellular Protein Homeostasis

• Regulatory proteins: Cyclins, transcription factors, tumor suppressors
• Damaged proteins: Oxidized, misfolded, or aggregate-prone proteins
• Foreign proteins: Viral and bacterial proteins [5]

Role in Neurons

• Maintains synaptic protein turnover
• Regulates neurotransmitter receptor degradation
• Controls degradation of misfolded proteins
• Participates in synaptic plasticity [6]

Role in Neurodegenerative Diseases

Alzheimer's Disease

PSMB9 is significantly upregulated in AD brain, particularly in: [@kottke2012]

Amyloid Plaque Regions: [@sava2015]

• Surrounding [microglia](/cell-types/microglia-neuroinflammation) show high PSMB9 expression
• Colocalizes with amyloid plaques in [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex) [7]

• PSMB9 is induced in neurons containing hyperphosphorylated [tau](/proteins/tau)
• May attempt to degrade tau aggregates [8]

• IFN-γ release from activated microglia induces PSMB9 expression
• The immunoproteasome may generate neoepitopes that trigger autoimmune responses
• Altered proteasome function contributes to [Aβ](/proteins/amyloid-beta) and tau accumulation [9]

Parkinson's Disease

In PD and related synucleinopathies:

[α-Synuclein](/proteins/alpha-synuclein) Metabolism:

• PSMB9 is upregulated in substantia nigra dopaminergic neurons
• May attempt to degrade α-synuclein aggregates
• Failure leads to proteasome impairment and cell death [10]

• PINK1 and Parkin regulate immunoproteasome activity
• Mitophagy deficits lead to accumulation of damaged proteins
• PSMB9 expression is altered in LRRK2 mutant models [11]

Amyotrophic Lateral Sclerosis

In ALS:

Protein Aggregation:

• [TDP-43](/mechanisms/tdp-43-proteinopathy) and SOD1 aggregates trigger immunoproteasome induction
• PSMB9 is upregulated in motor neurons and glia
• Proteasome impairment is a common feature in ALS [12]

• Activated microglia produce IFN-γ, inducing PSMB9
• Immunoproteasome generates antigenic peptides
• May contribute to autoimmune mechanisms in ALS [13]

Multiple Sclerosis

Demyelination:

• PSMB9 is upregulated in active demyelinating lesions
• Involved in myelin protein degradation during demyelination
• May generate antigenic peptides for T cell recognition [14]

• Immunoproteasome is essential for myelin antigen presentation
• PSMB9 polymorphisms are associated with MS susceptibility
• Therapeutic targeting is under investigation [15]

Huntington's Disease

Mutant [Huntingtin](/proteins/huntingtin) Degradation:

• PSMB9 attempts to degrade mutant huntingtin aggregates
• Chronic induction leads to proteasome exhaustion
• Altered proteasome function contributes to neurodegeneration [16]

Signaling Pathways

Interferon Signaling

• STAT1/IRF1 pathway upregulates PSMB9 expression
• JAK-STAT signaling in response to IFN-γ
• [NF-κB](/entities/nf-kb) can also induce immunoproteasome subunits [17]

Nrf2-ARE Pathway

• Oxidative stress activates Nrf2
• Nrf2 binds to antioxidant response elements
• Can induce proteasome subunit expression [18]

NF-κB Pathway

• Pro-inflammatory cytokines activate NF-κB
• NF-κB can induce PSMB9 transcription
• Creates feedback loop in chronic inflammation [19]

Therapeutic Targeting

Proteasome Inhibitors

Immunoproteasome-Selective Inhibitors

• ONX-0914 (PR-957): Selectively inhibits β5i, reduces autoimmune T cell responses [20]
• LMP7-IN-1: Direct LMP7 (β5i) inhibitor, protects neurons in models [21]

Proteasome Activators

• Natural compounds: Sulforaphane, curcumin can enhance proteasome activity
• Small molecules: Being developed to boost proteasome function in neurodegeneration [22]

Biomarkers

• CSF PSMB9: Elevated in AD, PD, and ALS vs. controls [23]
• Blood PSMB9: May serve as peripheral inflammation marker
• Proteasome Activity: Reduced in AD brain, potential biomarker [24]

Overview

Psmb9 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Psmb9 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• PSMB9 Gene - Gene encoding PSMB9
• PSMB8 Protein - Immunoproteasome subunit (LMP7)
• PSMB10 Protein - Immunoproteasome subunit (LMP10)
• PSMA5 Protein - Proteasome alpha subunit
• Ubiquitin-Proteasome Pathway - Protein degradation pathway
• Neuroinflammation Pathway - Inflammatory mechanisms in neurodegeneration
• [MHC Class I](https://en.wikipedia.org/wiki/MHC_class_I) - Antigen presentation pathway
• [Alzheimer's Disease](/diseases/al- [Parkinson's Disease](/diseases/parkinsons-disease) in AD
• [Parkinson's Disease](/diseases/parkinsons-disease) PSMB9 in PD
• ALS - PSMB9 in ALS

External Links

• [UniProt: P28065 (PSMB9)](https://www.uniprot.org/uniprot/P28065)
• [GeneCards: PSMB9](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSMB9)
• [NCBI Gene: 5698](https://www.ncbi.nlm.nih.gov/gene/5698)
• [PubMed: PSMB9 AND neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=PSMB9+neurodegeneration)

Cross-References

• [genes/psmb9](genes/psmb9) - PSMB9 Gene
• [proteins/psmb8](proteins/psmb8) - PSMB8 Protein (LMP7)
• [proteins/psmb10](proteins/psmb10) - PSMB10 Protein (LMP10)
• [proteins/psma5](proteins/psma5) - PSMA5 (proteasome alpha subunit)
• [diseases/alzheimers](diseases/alzheimers) - Alzheimer's Disease
• [diseases/parkinsons](diseases/parkinsons) - Parkinson's Disease
• [diseases/als](diseases/als) - Amyotrophic Lateral Sclerosis
• [diseases/multiple-sclerosis](diseases/multiple-sclerosis) - Multiple Sclerosis
• [diseases/huntingtons](diseases/huntingtons) - Huntington's Disease
• [pathways/ubiquitin-proteasome](pathways/ubiquitin-proteasome) - Ubiquitin-Proteasome Pathway
• [pathways/neuroinflammation](pathways/neuroinflammation) - Neuroinflammation Pathway
• [pathways/mhc-class-i](pathways/mhc-class-i) - MHC Class I Antigen Presentation

References